PAR 2.38% 21.5¢ paradigm biopharmaceuticals limited..

Where we at?, page-684

  1. 773 Posts.
    lightbulb Created with Sketch. 220
    Might hear something from the FDA in the next couple of weeks as mentioned. Hope it's straightforward and in PAR's favour if there are any adjustment to the protocol's. Share action interesting- probably a lot of pre tax adjusting and some just capitulating so opening up opportunities for long holder's or some speculating on FDA news. Now looks like a base prior to the news. Any leak look for an increase (hopefully not the other way!!) -it's happened previously unfortunately. I really can't see the P3 not going ahead, it's just time and money now. GLTA
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.